Mirum Pharma drops on announcing $600 mln convertible debt deal
View all comments(0)
Shares of Mirum Pharmaceuticals MIRM.O drop 2% to $104.64 in extended trading as it seeks capital
MIRM announces private offering of $600 mln convertible bonds (CBs) due 2032
Co intends to use portion of net offering proceeds and issue common stock in exchange for a portion of its outstanding 4% CBs due 2029, remainder for general corp purposes
MIRM stock ended up 0.7% at $106.88 on Tues, up 35% YTD
Co last week said its rare liver disease drug, volixibat, met main goal in mid-stage study
Foster City, California-based co has $6.5 bln market cap
All 11 analysts are bullish on the stock including 4 "strong buy" ratings; median PT of $140 up from $128 a month ago, per LSEG data
Disclaimer: The information provided on this website is for educational and informational purposes only and should not be considered financial or investment advice.
Like
Recommended Articles
Featured Tools
Top News
Cerebras Systems IPO 2026: Date, Price, Valuation, and Whether CBRS Is Worth Buying

April 2026 CPI Preview: Will Hot Inflation Crush Nasdaq, S&P 500 & NVDA? Explosive Market Reaction Guide

Copper Prices Near All-Time Highs. Citi: If Strait of Hormuz Is Unblocked, Price Will Rise to $15,000 by Year-End

SK Hynix Surges 15% to New High: HBM Shortage Until 2028, How Much Longer Can AI Memory King Rise?

PPI Report April 2026: How Inflation Data Is Moving HIMS, CEG, and PLUG Stock Today

Tradingkey







Comments (0)
Click the $ button, enter the symbol, and select to link a stock, ETF, or other ticker.